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238* Working capacity and oxygen uptake in CF
M. Gilljam1,3, A. Lindblad1,2, P. Gustafsson2, T. Gilljam2. 1West Swedish CF
Centre, Go¨teborg, Sweden; 2Queen Silvia Children’s Hospital, Go¨teborg, Sweden;
3Sahlgrenska University Hospital, Go¨teborg, Sweden
A cross-sectional study of exercise capacity in all CF patients over 10 years of age
was attempted. Exclusion criteria were previous lung transplantation (6 patients) and
colonisation with certain multiresistant bacteria (5 patients). Of 81 eligible patients
23 declined participation or were deemed unsuitable for the exercise protocol. In
58 participants (53% males) with a mean age of 24±9 years, FEV1 was 78±14%
of predicted. Pancreatic insufﬁciency was present in 78% and CF-related diabetes
in 10%. The genotype group was DF508/DF508 in 53%, DF508/other in 40%
and other/other in 7%. A cycle ergometer exercise protocol with increments of
10−30W/min was performed as determined by previous year’s test. Heart rate, blood
pressure, ventilation and pulmonary gas exchange were monitored until maximum.
At peak exercise heart rate was 180±12 bpm, respiratory rate 46±9/min and
respiratory quotient (V′CO2/V′O2) 1.23±0.74 and ventilatory quotient (VE/V′O2)
was 40±6, all indicating a physiologic maximum. The mean maximum work load
(206±63 W, 3.3±0.8 W/kg body weight), and oxygen uptake 2.48±0.69 L/min
(39±8ml/kg/min) was normal. Despite higher FEV1% predicted in children (<18
years), there was no difference between adults and children for peak performance
or oxygen uptake per kg body weight.
Conclusion: In adult CF patients with relatively well-preserved lung function,
normal exercise capacity is attainable up to young middle age.
239 Clinical and polysomnographic proﬁle in miscigenated patients
with cystic ﬁbrosis
R.T. Ramos1, P.B. Grego´rio1, I.C. Salles1, C.H. Daltro1, A. Tunes1,
M.A. Santana1, A.X. Acosta1. 1EBMSP, FBDC, Salvador, Bahia, Brazil
No data exists on Obstructive Sleep Apnea Syndrome (OSAS) prevalence in chil-
dren with Cystic Fibrosis (CF) and little data on the sleep architecture considering
racial miscigenated group.
Objective: describe clinical and polysomnographic characteristics in clinically
stable children with CF.
Study design: cross sectional study.
Material and Methods: 65 patients between 2 and 14-years-old from Hospital
Octa´vio Mangabeira, in Salvador, Bahia, Brazil, were studied from November 2006
up to October 2007. We evaluated age, gender, z-score weight/age, Shwachman–
Kulczycki (S–K) score, snoring, restless sleep, sleep efﬁciency (SE), REM latency,
percentage of sleep stages 1, 2, 3, 4 and REM sleep, apnea index (AI), oxygen
saturations.
Results: 56.9% were male; age range was from 2 to 14-years-old, mean and SD
7.6±3.1 years. The majority of population (80%/65) was composed of black and
mulatto children. Median and SD z-score weight/age was −0.462±1.14. Mean and
SD S-K score of patients was 85.43±9.42. Sleep complains were snoring in 50.7%
and restless sleep in 76.9%. Mean SE was 81.25%±10.75%; median and SD REM
latency was 170.32±109.65; median and SD stage 1 was 7.38±3.9, stage 2 was
39.6±11.39, stage 3 was 3.4±1.2 and stage 4 was 21.8±6.9; median and SD stage
REM was 14.3±7.7. Median AI was 1.00±1.94 events/sleep hour, range 0–11
events/sleep hour. 53.8% had mild OSAS, 4.6% moderate OSAS and 1.5% severe
OSAS. The oxygen saturation nadir values were 81.6±5.7 range 70%-92%.
Conclusion: Our patients with CF had frequent sleep complaints and signiﬁcant
changes in their sleep architecture. The majority of our CF children had mild
obstructive sleep apnea. The results call attention because may have a signiﬁcant
on quality of life and clinical outcomes in this population.
240 Wisconsin–Brittany CF Newborn Screening Study: Comparison
of progression of lung disease using the Wisconsin Chest X-ray
scoring system in two screened cohorts
G. Rault1, A. Cunningham2, Z. Li2, A. Laxova2, L. Gue´ganton1, I. Dugue´pe´roux3,
M. Roussey4, C. Fe´rec3, V. Scotet3, P. Farrell2. 1Centre de Re´fe´rence
Mucoviscidose, Nantes, France; 2Univ Wisconsin, School of Medicine and
Public Health, Madison, WI, USA; 3Inserm U613, Brest, France; 4ARDPHE-
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Aim: This study compares the longitudinal progression of lung disease in CF
patients identiﬁed through newborn screening in Wisconsin and Brittany.
Methods: The study included 115 patients screened in Brittany and 69 patients
screened in Wisconsin, between 1989 and 2000. Lung disease was radiographically
quantiﬁed using the Wisconsin Chest X-ray (WCXR) and the Brasﬁeld Chest
X-ray (BCXR) scoring systems. De-identiﬁed ﬁlms were scored by a single
pediatric pulmonologist. Generalized estimating equation (GEE) models were used
to compare longitudinal progression of scores in the two cohorts and were adjusted
for gender, age, genotype, pancreatic insufﬁciency, and meconium ileus.
Results: 1364 ﬁlms were scored (an average of 7.4 per patient). Quality con-
trol revealed reproducible results in scoring over time. Adjusted GEE analysis
showed worse WCXR scores in Brittany patients compared to Wisconsin patients
(3.46±0.78; p< 0.0001) whereas this was not found with the BCXR scores
(−0.29±0.22; p = 0.19). By examining subcomponents of WCXR scores, there
were signiﬁcant differences in bronchiectasis, peribronchial thickening, nodule, and
hyperinﬂation but not in opacity or atelectasis.
Conclusion: The ﬁnding of milder radiographically-quantiﬁed lung disease using
the WCXR scoring system in Wisconsin patients may be explained by variations in
clinical practices or an unmeasured confounder. Further investigations are needed
to elucidate these ﬁndings.
Thanks to the Re´seau Muco Ouest.
241* Walking distance as an outcome of antibiotic course in patients
with cystic ﬁbrosis
G.L. Grzincich1, M.C. Tripodi1, S. Faverzani1, F. Longo1, M. Corchia1,
C. Spaggiari1, R. Minari1, G. Pisi1. 1Cystic Fibrosis Unit, Dept of Pediatric,
University of Parma, Italy
The six-minute walking test (6MWT) is widely used to evaluate exercise capacity
in patients with Cystic Fibrosis (CF). We evaluated the 6MWT changes induced
by an antibiotic iv course and their relationships with the change in pulmonary
function in a group of CF patients.
We studied 33 CF inpatients (19 F, mean age 23.9±SD 7.3, range 14–42 yrs), who
received an anti-pseudomonal antibiotic iv course for at least two weeks. In each
patient, forced vital capacity (FVC), forced expiratory volume at 1 second (FEV1),
walk distance (WD), oxygen saturation (SpO2) and pulse rate (PR) at rest and
during walk, dyspnoea after walk assessed by visual analogue scale (VAS) were
measured before and after the antibiotic course. Results (mean±SD) are listed in
the table.
No signiﬁcant relationship was found between the changes in 6MWT and the
corresponding in pulmonary function test variables. Our results show that in CF
patients the walking distance improved signiﬁcantly after antibiotic iv course, and
its change is not related to pulmonary function changes. This study suggests that the
walking distance may be used as an outcome measure of therapeutic interventions
in CF patients.
Before After Before After
WD (mt) 625±11* 645±11 PR during walk (bpm) 152±21* 159±19
SpO2 rest (%) 96.7±1.3* 97.2±1.2 VAS (mm) 45±20 42±21
SpO2 during walk (%) 93.6±6 94.4±4.1 FVC (% pred) 85±18* 95±20
PR rest (bpm) 104±15* 97±16 FEV1 (% pred) 63±19* 72±22
p value by means of paired t test, *p< 0.05
